BIM 23042 Acetate

SKU: orb1306249

Description

BIM 23042 Acetate is a selective neuromedin B receptor antagonist. This cyclic peptide is utilized in research to investigate the physiological roles of neuromedin B, including in cancer cell proliferation and smooth muscle contraction, in both in vitro and in vivo experimental models.

Research Area

Cell Biology

Key Properties

• MW: 1252.5
• Purity: 99.07% (May vary between batches)
• Formula: C₆₅H₇₇N₁₁O₁₁S₂
• SMILES: O=C([C@@H](NC([C@H](C(C)C)NC([C@H](CCCCN)NC([C@@H](CC1=CNC2=C1C=CC=C2)NC([C@H](CC3=CC=C(O)C=C3)N4)=O)=O)=O)=O)CSSC[C@H](NC([C@H](N)CC5=CC=C6C=CC=CC6=C5)=O)C4=O)N[C@H](CC7=CC=C8C=CC=CC8=C7)C(N)=O.CC(O)=O
• Target: Others
• Solubility: DMSO:65 mg/mL (51.9 mM)

Bioactivity

• In Vitro:
  BIM 23042 competitively inhibited neuromedin B-induced endpoint in huNMBR cells. BIM 23042 has a l00-fold greater affinity for BB1 receptors than BB2 receptors.
  Read more...

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

111857-96-6, 111857-96-6 Free base, BIM 23042 Acetate, BIM 23042 Acetate (111857-96-6 Free base), BIM23042 Acetate, BIM-23042 Acetate

Compound Identifiers

PubChem CID

163285850